Aug 10, 2026 · 7 min
Berkshire gains as software and biotech stocks unravel
Berkshire Jumps, Monday.com Falls, Tenax Plummets
The episode contrasts durable operating strength and shareholder returns with the sharp downside facing companies exposed to weak forecasts or failed drug trials.
- 1Berkshire rose after strong operating results and roughly $4.5 billion in share buybacks.
- 2Monday.com fell after issuing a weaker revenue outlook amid concerns about AI disruption and software credit exposure.
- 3Tenax Therapeutics plunged more than 90% when its Phase 3 drug trial missed its primary endpoint.
Don't miss
Tenax Therapeutics’ shares plunge more than 90% after its Phase 3 drug trial fails to meet the primary endpoint.
The brief
Tim Stenebeck, Nora Melinda, and Emily Graffeo frame a market roundup built around three very different kinds of stock moves: operating strength, a weaker outlook, and a failed clinical trial.
Berkshire Hathaway gains after strong results, with roughly $4.5 billion in share buybacks and strength across its manufacturing, services, and retailing businesses.
Monday.com comes under pressure after a weak revenue forecast, while the discussion widens to AI disruption and private credit exposure across software companies.
Tenax Therapeutics delivers the episode’s sharpest reversal: its shares plunge more than 90% after a Phase 3 drug trial fails to meet its primary endpoint.
The closing preview shifts from daily market volatility to urban growth, asking how AI and smarter infrastructure can help cities respond to rapid population increases.
What was said on this episode
7 statements · 4 positive · 3 negative
Berkshire Hathaway’s manufacturing, services, and retailing gains lifted operating earnings.
“They also had gains in the manufacturing service and retailing division that helped lift operating earnings over the period.”
Listen at 1:21
Private credit invested heavily in software companies, followed by a market reckoning.
“Private credit just kind of dumped so much money into software names. And there's been a little bit of a reckoning.”
Listen at 2:38
TenX Therapeutics shares fell more than 90% in one day.
“The shares plummeted over 90% today.”
Listen at 3:25
TenX Therapeutics has approximately $50 million market capitalization after erasing $450 million.
“It's only now about $50 million in market cap, but of course it had erased about $450 million.”
Listen at 4:03
AI will accelerate processes in smart-city development.
“AI will allow in the smart city space to compress a lot of things. the speed will change.”
Listen at 4:57
Dubai responded effectively to its sudden population increase.
“I think Dubai has learned a lot from a sudden increase in population, which doesn't happen everywhere in the world. And I think they reacted very well to it.”
Listen at 5:17
Dubai has a long-term urban-planning vision uncommon worldwide.
“They have a long-term urban planning vision, which again doesn't happen everywhere in the world.”
Listen at 5:25
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Bloomberg: Business News DailyBooks & mentions
Economy at Scale
Its urban-development coverage extends the episode’s preview of AI, infrastructure, and rapid population growth.
Listen to the full episode and explore every guest, topic, and moment on PodLume.